The Efficacy and Safety Profile of Netarsudil 0.02% in Glaucoma Treatment: Real-World Outcomes

被引：0
|
作者：
Ustaoglu, Melih [1 ]
Shiuey, Eric [2 ]
Sanvicente, Carina [1 ]
Razeghinejad, Reza [1 ]
Katz, L. Jay [1 ]
Myers, Jonathan S. [1 ]
Lee, Daniel [1 ]
机构：
[1] Wills Eye Hosp & Res Inst, Glaucoma Res Ctr, Philadelphia, PA USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Sch, Philadelphia, PA 19107 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2393
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
    Zeng, Jing-Xin
    Luo, Quan
    Wen, Ju
    Tian, Xin
    Zhou, Xin
    Li, Wei
    Tang, Ya-Ping
    Zhang, San-Quan
    Liu, Wei-Yu
    Zhu, Hui-Lan
    Zhang, Xi-Bao
    [J]. CHINESE MEDICAL JOURNAL, 2021, 134 (01) : 117 - 119
  • [22] The “real-world” efficacy and safety of DAAs for the treatment of HCV patients throughout Japan
    Shinya Maekawa
    Nobuyuki Enomoto
    [J]. Journal of Gastroenterology, 2018, 53 : 1168 - 1169
  • [23] Clinical Efficacy, Safety, Tolerability, and Real-World Data of Patiromer for the Treatment of Hyperkalemia
    Colbert, Gates
    Sannapaneni, Shilpa
    Lerma, Edgar, V
    [J]. DRUG HEALTHCARE AND PATIENT SAFETY, 2022, 14 : 87 - 96
  • [24] The "real-world" efficacy and safety of DAAs for the treatment of HCV patients throughout Japan
    Maekawa, Shinya
    Enomoto, Nobuyuki
    [J]. JOURNAL OF GASTROENTEROLOGY, 2018, 53 (10) : 1168 - 1169
  • [25] Real-world investigation of the efficacy and safety of secukinumab for psoriasis treatment in a Chinese population
    Zeng Jing-Xin
    Luo Quan
    Wen Ju
    Tian Xin
    Zhou Xin
    Li Wei
    Tang Ya-Ping
    Zhang San-Quan
    Liu Wei-Yu
    Zhu Hui-Lan
    Zhang Xi-Bao
    [J]. 中华医学杂志(英文版), 2021, 134 (01) : 117 - 119
  • [26] The efficacy and safety of pembrolizumab in advanced cervical cancer: A real-world treatment study
    Browne, I.
    Chew, S.
    Fennelly, D.
    Crown, J.
    Murray, H.
    Rahman, R.
    McCaffrey, J.
    Kelly, C.
    Osman, N.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1438 - S1439
  • [27] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Zmira, Ofir
    Halpern, Alex, I
    Abraham, Lital
    Achiron, Anat
    [J]. ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1513 - 1518
  • [28] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Ofir Zmira
    Alex I. Halpern
    Lital Abraham
    Anat Achiron
    [J]. Acta Neurologica Belgica, 2021, 121 : 1513 - 1518
  • [29] Comparison of safety and efficacy of Netarsudil 0.02% and Bimatoprost 0.01% monotherapy and combination therapy in primary open-angle glaucoma and ocular hypertension
    Shahid, Saima
    Rizvi, Syed Wajahat A.
    Khan, Adeeb A.
    Ashraf, Humayoun
    Akhter, Afeefa
    [J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (03) : 427 - 431
  • [30] Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients
    Verkkoniemi-Ahola, Auli
    Hartikainen, Paivi
    Hassi, Katja
    Kuusisto, Hanna
    Lahdenpera, Sanni
    Mehtala, Juha
    Viitala, Matias
    Ylisaukko-oja, Tero
    Soilu-Hanninen, Merja
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (04)
12345